CELLBXHEALTH PLC (CLBX) — Investor Presentation and Q&A

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the CELLBX Health PLC investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can review all questions submitted today and publish responses what is appropriate to do so. Before we begin, I would like to submit the following poll, and I would now like to hand you over to CEO Peter Collins. Good afternoon to you. Thank you. Good afternoon. Peter Collins, CEO at CELLBXHEALTH, and looking forward to share the latest around how we are moving the company forward with a new strategy and business plan. On the call today with myself presenting, my colleague Sinead Armstrong, our FD, if you'd like to introduce yourself. Yeah. I'm Sinead Armstrong. I have been with CELLBX, formerly Anglo, over the last twenty five years in various roles within finance doing my current role for about the last seven to eight years. Thank you, Sinead. Unfortunately, on this part of the presentation, our executive chairman, Jan Groen, can't join us, But Jan has significant experience in the diagnostic industry. Some companies here has been involved in establishing from Europe and successfully transitioned them into The US. Two of them you can you can see there with Agenda and the company MDXHEALTH. And Jan and I have previously worked together from my own from my own side. You know, I spent the last twenty five years or so in senior executive roles across either oncology, diagnostic, or drug development, and in many cases, both...